# H. Pylori Eradication for Moderate ITP

> **NCT03177629** · PHASE3 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 54 (estimated)

## Conditions studied

- Immune Thrombocytopenic Purpura
- Helicobacter Pylori
- Immune Thrombocytopenia

## Interventions

- **DRUG:** treatment : H. pylori eradication

## Key facts

- **NCT ID:** NCT03177629
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-23
- **Primary completion:** 2020-06
- **Final completion:** 2020-12
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2018-09-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03177629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03177629, "H. Pylori Eradication for Moderate ITP". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03177629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*